← Leaderboards
Gordon J Lutz
Veterans Medical Research Fdn/San Diego
$4,880,615
Attributed
$4,880,615
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2009–16$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,880,615 · 5
By mechanism
R44$2,758,329 · 1
R01$1,166,593 · 2
R21$498,728 · 1
R43$456,965 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Protein Isoforms”
- Randall J Bateman · Washington University$79,170,583
- Rolf Apweiler · European Molecular Biology Laboratory$41,336,566
- Stanley B Prusiner · University Of California San Francisco$33,187,893
- Howard Y Chang · Stanford University$26,252,541
- David A Bennett · Rush University Medical Center$25,855,566
- Yadong Huang · J. David Gladstone Institutes$24,532,318
Research focus
Protein IsoformsAmyotrophic Lateral SclerosisGlutamatesVariantAmpa ReceptorsDoseMotor NeuronsMediatingRna SplicingResponseDesensitizationLeadExcitotoxicityCessation Of LifeBaseDesignBiomechanicsMuscle ContractionIn VivoPropertyInfusion ProceduresIon ChannelClinical TrialsDrug Development
Grant awards (15)
Preclinical testing of the splice modulating oligonucleotide LSP-GR1$965,278
R44 · FY2016 · NS · contact PI
Preclinical testing of the splice modulating oligonucleotide LSP-GR1$1,033,937
R44 · FY2015 · NS · contact PI
Preclinical testing of the splice modulating oligonucleotide LSP-GR1$759,114
R44 · FY2014 · NS · contact PI
Oligonucleotides that Modulate AMPA Receptor Alternative Splicing as Drug Candida$141,964
R43 · FY2012 · NS · contact PI
Oligonucleotides that Modulate AMPA Receptor Alternative Splicing as Drug Candida$315,001
R43 · FY2011 · NS · contact PI
Targeting AMPA Receptor Splicing as a Therapeutic Approach for ALS$192,394
R21 · FY2010 · NS · contact PI
Targeting AMPA Receptor Splicing as a Therapeutic Approach for ALS$76,959
R21 · FY2010 · NS · contact PI
Targeting AMPA Receptor Splicing as a Therapeutic Approach for ALS$229,375
R21 · FY2009 · NS · contact PI
CHARACTERIZATION OF MECHANICAL BASED INJURY IN MUSCLE$134,730
R01 · FY2002 · AR
CHARACTERIZATION OF MECHANICAL BASED INJURY IN MUSCLE$77,288
R01 · FY2002 · AR
CHARACTERIZATION OF MECHANICAL BASED INJURY IN MUSCLE$210,577
R01 · FY2001 · AR
STRUCTURE/FUNCTION OF MYOSIN IN SKELETAL MUSCLE$194,314
R01 · FY2001 · AR
STRUCTURE/FUNCTION OF MYOSIN IN SKELETAL MUSCLE$57,183
R01 · FY2001 · AR
CHARACTERIZATION OF MECHANICAL BASED INJURY IN MUSCLE$261,752
R01 · FY2000 · AR
STRUCTURE/FUNCTION OF MYOSIN IN SKELETAL MUSCLE$230,749
R01 · FY2000 · AR